Innovative Technologies for Differential Diagnosis of Acute Febrile Illnesses (R21/R33)
The summary for the Innovative Technologies for Differential Diagnosis of Acute Febrile Illnesses (R21/R33) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Innovative Technologies for Differential Diagnosis of Acute Febrile Illnesses (R21/R33): The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for early-stage translational research projects focused on the development of innovative, unbiased next generation, differential diagnostic technologies for acute febrile illnesses caused by infectious pathogens, excluding HIV.
Federal Grant Title: | Innovative Technologies for Differential Diagnosis of Acute Febrile Illnesses (R21/R33) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-AI-14-062 |
Type of Funding: | Grant |
CFDA Numbers: | 93.855, 93.856 |
CFDA Descriptions: | Allergy, Immunology and Transplantation Research; Microbiology and Infectious Diseases Research |
Current Application Deadline: | Feb 2, 2015 |
Original Application Deadline: | Feb 2, 2015 |
Posted Date: | October 15th, 2014 |
Creation Date: | Oct 15, 2014 |
Archive Date: | Mar 5, 2015 |
Total Program Funding: | $5,400,000 |
Maximum Federal Grant Award: | none |
Minimum Federal Grant Award: | none |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Native American tribal governments (Federally recognized)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Public housing authorities/Indian housing authorities
City or township governments
State governments
Small businesses
For profit organizations other than small businesses
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Private institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Special district governments
County governments
Independent school districts - Additional Information on Eligibility
- Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed. - Link to Full Grant Announcement
- http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-14-062.html
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
National Institutes of Health 301-496-3405 - Similar Government Grants
- • Center of Excellence for Systems Modeling of Infection and Immunity across Biological Scal...
- • NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
- • NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Tria...
- • Novel Approaches for Radiation Biodosimetry Assays and Devices Development (U01 Clinical T...
- • Understanding Mechanisms and Outcomes of Trained Immunity (R21 Clinical Trial Not Allowed)
- • Center for HIV/AIDS Vaccine Immunology (CHAVI)
- • Genomics of Transplantation Cooperative Research Program
- • Asthma and Allergic Diseases Cooperative Research Centers
- More Grants from the National Institutes of Health
- • Botanical Dietary Supplements Translational Research Teams (RM1 Clinical Trial Required)
- • Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)
- • Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clin...
- • Research on the Neuro-Immune Axis in the context of HIV and Substance Use (R01 Clinical Tr...
- • Limited Competition: Research Resource for Natural Product Nuclear Magnetic Resonance Data...